Y-mAbs Therapeutics, Inc.
Y-mAbs Therapeutics, Inc. (YMAB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · YMAB · as of Jun 9, 2026
Key Statistics
Explore Y-mAbs Therapeutics, Inc. Data
ymab stock data · financialsCompetitors & Peers
ymab competitorsYMAB
BCYP
CKPT
CLYM
GTHX
ITOSAbout Y-mAbs Therapeutics, Inc.
Y-mAbs Therapeutics, Inc. is a biopharmaceutical firm already generating revenue, dedicated to discovering, advancing, and selling innovative antibody-derived therapies specifically designed to combat…
what is y-mabs therapeutics, inc. · ymab stock overview · y-mabs therapeutics, inc. company profile · who is y-mabs therapeutics, inc. ceo · ymab NASDAQ · y-mabs therapeutics, inc. headquarters · y-mabs therapeutics, inc. business segments
About Stock Overview & Key Data
Y-mAbs Therapeutics, Inc. (YMAB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 21, 2018. As of the latest trading session, YMAB stock price is $8.61, with a market capitalization of $391.2M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Y-mAbs Therapeutics, Inc. (YMAB) stock price is $8.61. The stock is traded on NASDAQ under the ticker symbol YMAB. The 52-week range is $3.55 – $16.11.